Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-7.52%
↑ 79% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-36.23%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -7.52% |
| 2024 | -57.55% |
| 2023 | -24.60% |
| 2022 | -47.69% |
| 2021 | 32.19% |
| 2020 | -19.16% |
| 2019 | -105.99% |
| 2018 | -29.25% |
| 2017 | -32.45% |
| 2016 | -70.26% |